CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network. - Choquet S; Soussain C; Azar N; Morel V; Metz C; Ursu R; Waultier-Rascalou A; di Blasi R; Houot R; Souchet L; Roos-Weil D; Uzunov M; et al. (American journal of hematology, 2024)